Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.14
-0.13 (-0.98%)
Apr 14, 2026, 4:00 PM EDT - Market closed
Dr. Reddy's Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 56,133 | 57,245 | 72,010 | 45,067 | 23,568 | 17,238 |
Depreciation & Amortization | 19,583 | 17,058 | 14,700 | 12,636 | 11,824 | 12,796 |
Stock-Based Compensation | 345 | 424 | 407 | 397 | 592 | 584 |
Other Adjustments | 23,445 | 21,683 | -1,455 | 19,344 | 18,059 | 21,519 |
Change in Receivables | -8,283 | -10,283 | -8,054 | -5,752 | -17,012 | 2,081 |
Changes in Inventories | -10,707 | -12,753 | -18,445 | -2,654 | -9,912 | -12,402 |
Changes in Accounts Payable | 4,788 | 340 | 3,460 | 23 | 4,412 | 2,861 |
Changes in Other Operating Activities | -20,582 | -27,286 | -17,190 | -10,186 | -3,423 | -8,974 |
Operating Cash Flow | 63,106 | 46,428 | 45,433 | 58,875 | 28,108 | 35,703 |
Operating Cash Flow Growth | 75.53% | 2.19% | -22.83% | 109.46% | -21.27% | - |
Capital Expenditures | -26,450 | -27,504 | -16,403 | -11,323 | -14,660 | -9,741 |
Sale of Property, Plant & Equipment | 142 | 512 | 1,064 | 82 | 370 | 85 |
Purchases of Intangible Assets | -12,398 | -6,894 | -11,032 | -7,543 | -4,389 | -2,820 |
Proceeds from Sale of Intangible Assets | 694 | 732 | 21 | - | 2,946 | - |
Purchases of Investments | -202,929 | -254,458 | -145,488 | -136,171 | -88,972 | -75,418 |
Proceeds from Sale of Investments | 188,137 | 279,576 | 129,784 | 112,805 | 77,771 | 79,528 |
Payments for Business Acquisitions | -1,706 | -53,413 | -12 | - | -326 | -15,514 |
Other Investing Activities | 2,183 | 3,372 | 1,783 | 777 | 873 | 1,220 |
Investing Cash Flow | -45,271 | -58,077 | -40,283 | -41,373 | -26,387 | -22,660 |
Short-Term Debt Issued | 6,753 | 24,490 | 5,493 | -19,382 | 3,520 | 6,791 |
Net Short-Term Debt Issued (Repaid) | 6,753 | 24,490 | 5,493 | -19,382 | 3,520 | 6,791 |
Long-Term Debt Issued | - | - | 3,800 | - | - | 3,800 |
Long-Term Debt Repaid | - | - | -3,800 | - | - | -3,743 |
Net Long-Term Debt Issued (Repaid) | - | - | 0 | - | - | 57 |
Issuance of Common Stock | 329 | 193 | 805 | 368 | 334 | -924 |
Repurchase of Common Stock | - | -1,389 | - | - | - | - |
Net Common Stock Issued (Repurchased) | 329 | -1,196 | 805 | 368 | 334 | -924 |
Common Dividends Paid | -6,659 | -6,662 | -6,648 | -4,979 | -4,146 | -4,147 |
Other Financing Activities | -5,153 | 2,279 | -3,413 | -2,868 | -2,130 | -2,075 |
Financing Cash Flow | -13,175 | 18,911 | -3,763 | -26,861 | -2,422 | -298 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 965 | 224 | -59 | 286 | 733 | 113 |
Net Cash Flow | 4,660 | 7,262 | 1,387 | -9,359 | -701 | 12,745 |
Free Cash Flow | 36,656 | 18,924 | 29,030 | 47,552 | 13,448 | 25,962 |
Free Cash Flow Growth | 93.70% | -34.81% | -38.95% | 253.60% | -48.20% | - |
FCF Margin | 10.58% | 5.81% | 10.40% | 19.34% | 6.27% | 13.68% |
Free Cash Flow Per Share | 50.57 | 22.69 | 34.83 | 57.16 | 16.17 | 31.22 |
Levered Free Cash Flow | 29,967 | 30,889 | 27,299 | 14,181 | 15,329 | 8,626 |
Unlevered Free Cash Flow | 16,000 | 3,416 | 18,598 | 31,157 | 9,750 | 385.93 |
Updated Jan 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.